Overview of the BioBank Japan Project: Study design and profile

Journal of Epidemiology

Volumn 27, Issue 3, 2017, Pages S2-S8

  Nagai, Akiko ^a   Hirata, Makoto ^a   Kamatani, Yoichiro ^b   Muto, Kaori ^a   Matsuda, Koichi ^a   Kiyohara, Yutaka ^c   Ninomiya, Toshiharu ^d   Tamakoshi, Akiko ^e   Yamagata, Zentaro ^f   Mushiroda, Taisei ^b   Murakami, Yoshinori ^a   Yuji, Koichiro ^a   Furukawa, Yoichi ^a   Zembutsu, Hitoshi ^a,g   Tanaka, Toshihiro ^h,i   Ohnishi, Yozo ^h,j   Nakamura, Yusuke ^a,k   Kubo, Michiaki ^b   Shiono, Masaki ^l   Misumi, Kazuo ^l   Kaieda, Reiji ^l   Harada, Hiromasa ^l   Minami, Shiro ^m   Emi, Mitsuru ^m   Emoto, Naoya ^m   Daida, Hiroyuki ⁿ   Miyauchi, Katsumi ⁿ   Murakami, Akira ⁿ   Asai, Satoshi ^o   Moriyama, Mitsuhiko ^o   Takahashi, Yasuo ^o   Fujioka, Tomoaki ^p   Obara, Wataru ^p   Mori, Seijiro ^q   Ito, Hideki ^q   Nagayama, Satoshi ^r   Miki, Yoshio ^r   Masumoto, Akihide ^s   Yamada, Akira ^s   Nishizawa, Yasuko ^t   Kodama, Ken ^t   Kutsumi, Hiromu ^u   Sugimoto, Yoshihisa ^u   Koretsune, Yukihiro ^v   Kusuoka, Hideo ^v   Yanai, Hideki ^w   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c Hisayama Research Institute for Lifestyle Diseases   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF YAMANASHI   (Japan)

^g NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^h RIKEN YOKOHAMA INSTITUTE   (Japan)

ⁱ TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^j Shinkokai Medical Corporation   (Japan)

^k UNIVERSITY OF CHICAGO   (United States)

^l Tokushukai Hospitals   (Japan)

^m NIPPON MEDICAL SCHOOL   (Japan)

ⁿ JUNTENDO UNIVERSITY   (Japan)

^o NIHON UNIVERSITY   (Japan)

^p IWATE MEDICAL UNIVERSITY   (Japan)

^q TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^r Cancer Institute Hospital of JFCR   (Japan)

^s ASO IIZUKA HOSPITAL   (Japan)

^t OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^u SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^v OSAKA NATIONAL HOSPITAL   (Japan)

^w Japan Anti Tuberculosis Association   (Japan)

more..

Author keywords

Biobank; BioBank Japan Project; Genomic research; Personalized medicine

Indexed keywords

BIOBANK; FEMALE; GENETICS; HUMAN; JAPAN; MALE; METHODOLOGY; MIDDLE AGED; PERSONALIZED MEDICINE; REGISTER;

BIOLOGICAL SPECIMEN BANKS; FEMALE; GENETIC RESEARCH; HUMANS; JAPAN; MALE; MIDDLE AGED; PRECISION MEDICINE; REGISTRIES; RESEARCH DESIGN;

EID: 85016438418     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.1016/j.je.2016.12.005     Document Type: Article

References (21)

1. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007;447:661e678
2. Welter D, MacArthur J, Morales J, et al. The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42:D1001eD1006
3. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793e795
4. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res. 2009;154:277e287
5. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010;363:301e304
6. BioBank Japan. Tailor-made Medical Treatment Program. https://biobankjp.org/ work/public.html. Accessed 1 July 2016
7. Nakamura Y. The BioBank Japan Project. Clin Adv Hematol Oncol. 2007;5: 696e697
8. BioBank Japan. A Brochure about the Distribution of Samples for Researchers [in Japanese]. Tailor-made Medical Treatment Program. https://biobankjp.org/ sample/pdf/panf_v2.0.pdf. Updated 7 March 2015. Accessed 1 July 2016
9. Hirata M, Nagai A, Kamatani Y, et al. Overview of BioBank Japan follow-up data in 32 diseases. J Epidemiol. 2017;27:S22eS28
10. Hirata M, Kamatani Y, Nagai A, et al. Cross-sectional analysis of BioBank Japan clinical data: a large cohort of 200, 000 patients with 47 common diseases. J Epidemiol. 2017;27:S9eS21
11. Gaskell G, Gottweis H. Biobanks need publicity. Nature. 2011;471:159e160
12. Scott CT, Caulfield T, Borgelt E, et al. Personal medicine e the new banking crisis. Nat Biotechnol. 2012;30:141e147
13. Collins R. What makes UK biobank special? Lancet. 2012;379:1173e1174
14. AURIA BIOPANKKI. What Is Auria Biobank? https://www.auriabiopankki.fi/ auria-biobank/?lang=en. Accessed 5 July 2016
15. Leitsalu L, Haller T, Esko T, et al. Cohort profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int J Epidemiol. 2015;44: 1137e1147
16. Gaziano JM, Concato J, Brophy M, et al. Million Veteran Program: a megabiobank to study genetic influences on health and disease. J Clin Epidemiol. 2016;70:214e223
17. National Institutes of Health. About the Precision Medicine Initiative Cohort Program. https://www.nih.gov/precision-medicine-initiative-cohort-program. Accessed 5 July 2016
18. Kuriyama S, Yaegashi N, Nagami F, et al. The Tohoku Medical Megabank Project: design and mission. J Epidemiol. 2016;26:493e511
19. Roden DM, Pulley JM, Basford MA, et al. Development of a large-scale deidentified DNA biobank to enable personalized medicine. Clin Pharm Ther. 2008;84:362e369
20. Olson JE, Ryu E, Johnson KJ, et al. The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin Proc. 2013;88:952e962
21. Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nat Rev Genet. 2006;7:812e820